Table 2 Aß peptides with acrolein-modified residues

Aß1-16

113.90

1953.87

- 2.2

652.2964

3

18.53

996

67

DAEFRh(+ 56.03)DSGYEVHHQK

113.72

2009.90

2

503.48

4

18.25

961

8

AEFRHDSGYEVh(+ 56.03)HQK

114.37

1894.87

1.1

474.73

4

18.02

934

1

DAEFRHDSGYEVh(+ 56.03)HQK

103.57

2009.90

1.3

670.97

3

19.83

1142

8

AEFRHDSGYEVHh(+ 56.03)QK

99.88

1894.87

1.5

379.98

5

18.09

943

1

DAEFRHDSGYEVHh(+ 56.03)QK

49.81

2009.90

1.1

402.99

5

51.7

3060

1

AEFRHDSGYEVHHQk(+ 38.02)

123.47

1876.86

0.9

470.22

4

18.11

945

2

DAEFRHDSGYEVHHQk(+ 38.02)

147.15

1991.89

4.8

664.97

3

21.56

1309

14

DAEFRHDSGYEVHHQk(+ 76.03)

58.39

2029.90

0.5

508.48

4

19.77

1135

1

DAEFRHDSGYEVHHQk(+ 94.04)

105.66

2047.91

2

512.99

4

18.59

1014

6

DAEFRh(+ 56.03)DSGYEVh(+ 56.03)HQK

70.98

2065.92

0.8

517.49

4

18.46

995

2

DAEFRh(+ 56.03)DSGYEVHHQk(+ 38.02)

58.64

2047.91

2.6

512.99

4

20.67

1225

1

DAEFRHDSGYEVh(+ 56.03)h(+ 56.03)QK

53.00

2065.92

4

414.19

5

19.46

1108

3

DAEFRHDSGYEVh(+ 56.03)HQk(+ 38.02)

68.40

2047.91

- 1

512.99

4

21.79

1331

2

DAEFRHDSGYEVHh(+ 56.03)Qk(+ 94.04)

81.45

2103.94

1.1

526.99

4

19.92

1150

3

Aß17-28

78.80

1324.67

1.5

442.5634

3

29.91

1610

22

LVFFAEDVGSNk(+ 38.02)

41.34

1362.69

0.8

682.35

2

29.8

1589

2

LVFFAEDVGSNk(+ 56.03)

27.51

1380.70

0.5

691.35

2

30.76

1669

1

LVFFAEDVGSNk(+ 76.03)

76.84

1400.70

0.8

701.36

2

30.74

1667

1

LVFFAEDVGSNk(+ 94.04)

60.88

1418.71

0.4

710.36

2

30.41

1644

2